You are here » Home » Companies » Company Overview » Shivalik Rasayan Ltd

Shivalik Rasayan Ltd.

BSE: 539148 Sector: Agri and agri inputs
NSE: SHIVALIK ISIN Code: INE788J01021
BSE 00:00 | 04 Oct 849.85 -9.40
(-1.09%)
OPEN

866.30

HIGH

870.40

LOW

840.00

NSE 00:00 | 04 Oct 846.35 -0.25
(-0.03%)
OPEN

863.45

HIGH

871.75

LOW

839.60

OPEN 866.30
PREVIOUS CLOSE 859.25
VOLUME 3554
52-Week high 1196.80
52-Week low 661.05
P/E 63.99
Mkt Cap.(Rs cr) 1,231
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 866.30
CLOSE 859.25
VOLUME 3554
52-Week high 1196.80
52-Week low 661.05
P/E 63.99
Mkt Cap.(Rs cr) 1,231
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Shivalik Rasayan Ltd. (SHIVALIK) - Chairman Speech

Company chairman speech

Dear Shareholders

It gives me great pleasure to present to you the Company's performance for the fiscalyear ended 31 March 2021. The year 2020-21 will be remembered as a year of the COVID-19etimes at least for most lif pandemic.Forthefirsttimein our of us there was a completeshutdown of mobility financial activity and vanity at large. the lockdowns were criticalto stop the spread but as a side effect the world saw a broken economic setup. Thefirst two quarters in particular were a slump for most sectors. however the gradualeasing of lockdowns and resumption of business activities allowed economies to breathe asigh of relief. the economy looked optimistic and India registered a V-shaped recovery bythe end of Q3. Vaccination drives were at par tourism was reopening logistical movementwas back. And just when we thought it was all ‘normal’ again a secondreiteration of COVID-19 deadlier and faster hit us hard. the Indian healthcare systemcollapsed with basic utilities and medicinal drugs going off the stock. April 2021 was theworst-hit month of the second wave. however this time around there was no nationwideunanimous lockdown rather the decision was left for respective state governments. thisfacilitated a higher mobility and flexibility in the financial aspect despite many statesimposing lockdowns. As we recover and leave behind the ills of the second wave the moveahead is towards recovery. the Company has moved through the pandemic adaptably andhumanely prioritising our employees and their health while also maintaining the sanctityand responsibility of professional deliverables.

SRL's day-to-day processes involve rigorous innovation a passion for chemistry andmanufacturing efficiency. The Company has always endeavoured to push forward in theseaspects. As a well-established company we are warming up to cease the variousopportunities the sector is likely to experience post the pandemic as well. We arewell-equipped to seize significant opportunities and continuing to provide high-qualityservices to our customers.

It is this calibre and dedication that has translated into consistent growth too.Despite the tough year and uncertain challenges we have all faced the Company hascontinued the positive momentum. During the financial year 2020-21 we registered revenuefigures at Rs.8486.60 lakhs and the EBITDA was reported at Rs. 1910.69 lakhs in2020-21. The Company recorded a PAT of Rs.1267.55 lakhs in 2020-21.

We have already secured WhO-GMP approvals for new Dahej plant. Our API plant is nowoperational and we have completed validations of 7 products. We are likely to file two DMFby December 2021. The Company is well-placed to deliver innovative and cost-effectivesolutions for the oncology segment in highly regulated markets. With so much on the tablethe time ahead is packed with rampant offerings and growth. the Board of Directors of theCompany have decided a strategic expansion to set up a green field Agro & SpecialityChemical Plant at Dahej-III GIDC Gujarat. the environmental Clearance (EC) from Ministryof Environment Forest and Climate Change has been received. the Company is in the processto raise fund through preferential issue to meet its project cost.

As I look forward I see Shivalik inching towards a position of market leadership as wecontinue the legacy of delivering relevant offerings which pack in cutting-edgetechnology and the latest equipment’s usage. I am proud of our highly competentR&D team's efforts and commitment to deliver which gives us more confidence indeveloping complex APIs in-house and moving towards a brighter future.

I would like to thank all our valued stakeholders for their continued support andencouragement. I'd like to express my gratitude to our vendors and partners for theirunwavering trust and cooperation. With our valuable Board of directors and synergy withour stakeholders we have embarked on a journey to a better future.

enternew markets while Best Wishes

Rahul Bishnoi

Chairman

.